Table 2. Prevalence of IDU-related diagnoses among patients with methicillin-resistant Staphylococcus aureus bloodstream infections, by IDU status, Tennessee, USA, 2015–2017*.

Diagnosis	IDU, no. (%), n = 1,839	Non-IDU, no. (%), n = 5,807	p value	Overall, no. (%), n = 7,646
Endocarditis	743 (40.4)	626 (10.8)	<0.001	1,369 (17.9)
Hepatitis C	932 (50.7)	377 (6.5)	<0.001	1,309 (17.1)
Osteomyelitis/septic arthritis	516 (28.1)	1,340 (23.1)	<0.001	1,856 (24.3)
Skin/soft tissue infection	863 (46.9)	2,227 (38.4)	<0.001	3,090 (40.4)

*IDU, injection drug use.